Explorative laparoscopy prior to exenterative surgery

Gynecologic Oncology

Volumn 86, Issue 3, 2002, Pages 311-315

  Köhler, Christhardt ^a   Tozzi, Roberto ^a   Possover, Marc ^a   Schneider, Achim ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLEEDING; COHORT ANALYSIS; CONTROLLED STUDY; EVALUATION; EVISCERATION; GYNECOLOGIC CANCER; HISTOLOGY; HUMAN; HUMAN TISSUE; LAPAROSCOPY; LAPAROTOMY; METASTASIS; OPERATION DURATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SURGICAL TECHNIQUE;

EID: 0036444112     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2002.6764     Document Type: Article

References (24)

1. Deckers PJ, Ketcham AS, Sugarbaker EV, Hoye RC, Thomas LB. Pelvic exenteration for primary carcinoma of the uterine cervix. Obstet Gynecol 1971;37:647-59.
2. Williams MP, Husband JE, Heron CW, Cherryman GR, Koslin DB. Magnetic resonance imaging in recurrent carcinoma of the cervix. Br J Radiol 1989;62:544-50.
3. Fyles A, Keane TJ, Barton M, Simm J. The effect of treatment duration in the local control of cervix cancer. Radiother Oncol 1992;25:273-9.
4. Goff B, Muntz HG, Paley P, Tamimi HK, Koh WJ, Greer BE. Impact of surgical staging in women with locally advanced cervical cancer. Gynecol Oncol 1999;74:436-42.
5. Miller B, Morris M, Rutledge F, Mitchell MF, Atkinson EN, Burke TW, Wharton JT. Aborted exenterative procedures in recurrent cervical cancer. Gynecol Oncol 1993;50:94-9.
6. Greer BE, Koh WJ, Stelzer KJ, Goff BA, Comsia N, Tran A. Expanded pelvic radiotherapy fields for treatment of local-regionally advanced carcinoma of the cervix: Outcome and complications Am J Obstet Gynecol 1996;174:1141-50.
7. Varia MA, Bundy BN, Deppe G, Mannel R, Averette HE, Rose PG. Connelly P. Cervical carcinoma metastatic to para-aortic nodes: Extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: A Gynecologic Oncology Group study. Int J Radiat Oncol Biol Phys 1998;42:1015-23.
8. Hacker NF, Warin GW, Nicklin JL. Resection of bulky positive lymph nodes in patients with cervical carcinoma. Int J Gynecol Cancer 1995;5:250.
9. Possover M, Krause N, Plaul K, Kühne-Heid RM, Schneider A. Laparoscopic paraaortic and pelvic lymphadenectomy: Experience with 150 patients and review of the literature. Gynecol Oncol 1998;78:19-28.
10. Plante M, Roy M. Operative laparoscopy prior to a pelvic exenteration in patients with recurrent cervical cancer. Gynecol Oncol 1998;69:94-9.
11. Shingleton HM, Soong SJ, Gelder MS, Hatch KD, Baker VV, Austin JM. Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix. Obstet Gynecol 1989;73:1027-34.
12. Hatch KD. The role of operative laparoscopy to evaluate candidates for pelvic exenteration. [Editorial] Gynecol Oncol 1998;69:93.
13. Vidaurreta J, Bermudez A, Di Paola G, Sardi J. Laparoscopic staging in locally advanced cervical carcinoma: A new possible philosophy? Gynecol Oncol 1999;75:336-71.
14. Whitney CW, Sause W, Bundy BN, Malfetano JH, Hannigan EV, Fowler WC, Clarke-Pearson DL, Liao SY. A randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative para-aortic lymphnodes. A Gynecologic Oncology Group study. J Clin Oncol 1999;17:1339-48.
15. Rose PG, Bundy BN, Watkins EB, Tate Thigpen J, Deppe G, Maiman MA, Clarke-Pearson DL, Insalaco S. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999;340:1144-53.
16. Van Nagell JR, Roddick JW, Lowin DM. The staging of cervical cancer: Inevitable discrepancies between clinical staging and pathologic findings Am J Obstet Gynecol 1971;110:973-8.
17. Lagasse LD, Creasman WT, Shingleton HM, Ford JH, Blessing JA. Results and complications of operative staging in cervical cancer: Experience of the Gynecologic Oncology Group. Gynecol Oncol 1980;9:90-8.
18. Heller PB, Malfetano JH, Bundy BN, Barnhill DR, Okagaki T. Clinical-pathologic study of stage IIb, III, IVa carcinoma of the cervix: Extended diagnostic evaluation for paraaortic node metastasis - A Gynecologic Oncology Group study. Gynecol Oncol 1990;38:425-30.
19. Hacker NF. Clinical and operative staging of cervical cancer. Baillieres Clin Obstet Gynaecol 1998;2:747-59.
20. Perez CA, Grigsby PW, Chao KS, Mutch DG, Lockett MA. Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix. Int J Radiat Oncol Biol Phys 1998;41:307-17.
21. Eifel PJ, Morris M, Wharton JT, Oswald MJ. The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1994;29:9.
22. Fletcher GH. Clinical dose-response curves of human malignant epithelial tumors. Br J Radiol 1973;46:1-12.
23. Morley GW, Hopkins MP, Lindenauer SM, Roberts JA. Pelvic exenteration, University of Michigan: 100 Patients at 5 years. Obstet Gynecol 1989;74:934.
24. Sheperd JH, Ngan HYS, Neven P, Fryatt I, Woodhouse CRJ, Hendry WF. Multivariate analysis of factors affecting survival in pelvic exenteration. Int J Gynecol Cancer 1994;4:361-370.